Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
The Journal of Urology|November 13, 2007
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinomaTobias Klatte, David B Seligson, John T Leppert, et al.Urologic Oncology|June 25, 2022
Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the programEmily H Roebuck, Samuel J Ivan, Myra M Robinson, et al.Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|August 28, 2025
A Quality Improvement Initiative Designed to Increase Veteran Choice and Consult RetentionMarina E Robson Chase, Madeline J Anderson, Wesley A Stephens, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinomaTobias Klatte, David B Seligson, Stephen B Riggs, et al.Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.Urology|April 12, 2020
Identifying a Break in the Chain: An Analysis of Where Ureteroscope Damage Occurs in the Hospital CycleMargaret M Higgins, Adam Dugan, John Roger Bell, et al.Journal of the American College of Surgeons|June 19, 2024
Surgical Intraoperative Handoff Initiative: Standardizing Operating Room Communication Using SHRIMPSWesley A Stephens, Madeline J Anderson, Brittany E Levy, et al.Cancer|October 1, 2008
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapiesArie S Belldegrun, Tobias Klatte, Brian Shuch, et al.Urology Practice|June 15, 2023
Examining and Understanding Value: The Cost of Preoperative Characteristics, Intraoperative Variables and Postoperative Complications of Minimally Invasive Partial NephrectomyAndrew M Harris, Patrick Hensley, Jeff Goodwin, et al.Pageof 7